Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Prevalance and characteristics of overlap syndrome in patients with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002
Predictors of obstructive sleep apnea syndrome and metabolic syndrome Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Prevalence of glaucoma in obstructive sleep apnea syndrome Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010
Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism Source: Sleep and Breathing Conference 2021 Year: 2021
Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002
Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism? Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006
Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006
Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011
Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006